These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 29621903
1. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo. Shao J, Glorieux C, Liao J, Chen P, Lu W, Liang Z, Wen S, Hu Y, Huang P. Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903 [Abstract] [Full Text] [Related]
3. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Roh JL, Kim EH, Jang H, Shin D. Redox Biol; 2017 Apr 06; 11():254-262. PubMed ID: 28012440 [Abstract] [Full Text] [Related]
4. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells. Yang X, Wang D, Ma Y, Xu X, Zhu Z, Wang X, Deng H, Li C, Chen M, Tong J, Yamanaka K, An Y. Toxicol Appl Pharmacol; 2015 Dec 01; 289(2):231-9. PubMed ID: 26420645 [Abstract] [Full Text] [Related]
5. NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer. Baird L, Yamamoto M. Mol Cell Biol; 2021 Jan 25; 41(2):. PubMed ID: 33139492 [Abstract] [Full Text] [Related]
6. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells. Li PC, Tu MJ, Ho PY, Jilek JL, Duan Z, Zhang QY, Yu AX, Yu AM. Drug Metab Dispos; 2018 Jan 25; 46(1):2-10. PubMed ID: 29061583 [Abstract] [Full Text] [Related]
7. In vivo imaging of antioxidant response element activity during liver regeneration after partial hepatectomy. Alizai PH, Bertram L, Fragoulis A, Wruck CJ, Kroy DC, Klinge U, Neumann UP, Schmeding M. J Surg Res; 2016 Dec 25; 206(2):525-535. PubMed ID: 27884351 [Abstract] [Full Text] [Related]
8. Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001. Ning S, Sekar TV, Scicinski J, Oronsky B, Peehl DM, Knox SJ, Paulmurugan R. Oncotarget; 2015 Aug 28; 6(25):21547-56. PubMed ID: 26280276 [Abstract] [Full Text] [Related]
9. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway. Chian S, Li YY, Wang XJ, Tang XW. Asian Pac J Cancer Prev; 2014 Aug 28; 15(6):2911-6. PubMed ID: 24761924 [Abstract] [Full Text] [Related]
10. Butylated hydroxyanisole induces distinct expression patterns of Nrf2 and detoxification enzymes in the liver and small intestine of C57BL/6 mice. Luo L, Chen Y, Wu D, Shou J, Wang S, Ye J, Tang X, Wang XJ. Toxicol Appl Pharmacol; 2015 Nov 01; 288(3):339-48. PubMed ID: 26291391 [Abstract] [Full Text] [Related]
11. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Deng X, Rui W, Zhang F, Ding W. Cell Biol Toxicol; 2013 Jun 01; 29(3):143-57. PubMed ID: 23525690 [Abstract] [Full Text] [Related]
14. Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling. Li L, Dong H, Song E, Xu X, Liu L, Song Y. Chem Biol Interact; 2014 Feb 25; 209():56-67. PubMed ID: 24361488 [Abstract] [Full Text] [Related]
20. Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury. Ge M, Yao W, Yuan D, Zhou S, Chen X, Zhang Y, Li H, Xia Z, Hei Z. Cell Death Dis; 2017 Jun 01; 8(6):e2841. PubMed ID: 28569786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]